Clinical trial
Ixabepilone Administered as an Enteric Coated Formulation.
NCT00309049 · R-Pharm, Industry · Completed
Key facts
| NCT number | NCT00309049 |
|---|---|
| Title | Ixabepilone Administered as an Enteric Coated Formulation. |
| Official title | An Exploratory Study of Ixabepilone Administered as an Enteric Coated Formulation in Patients With Advanced Cancer. |
| Lead sponsor | R-Pharm, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | Ixabepilone |
| Enrollment | 30 |
| Start date | Apr 1, 2006 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Mar 31, 2006 |
| Last update posted | Jan 30, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: